HIGHLIGHTS
- who: Senlong Yu and colleagues from the Department of Gastrointestinal Surgery, People`s Hospital of Zhejiang Province (Zhuji Afliated Hospital of Shaoxing University), China have published the paper: CSRP1 Promotes Colon Adenocarcinoma Growth and Serves as an Independent Risk Biomarker for Worse Prognosis, in the Journal: Genetics Research of 18/04/2023
- what: The authors not only analyzed the clinical relevance between CSRP1 and COAD survival, but also validated its tumor-promoting efect through cellular and mice experiments.
- how: All the experiments were conducted in triplicates.
- future: The underlying functional mechanisms . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.